BSECompany Update3 Aug 2026 · 3 Aug 2026, 06:53 pm
Investor Presentation
Krishna Institute of Medical Sciences Ltd · 543308
✦ AI SummaryResults
Krishna Institute of Medical Sciences Ltd has released an investor presentation for unaudited Q1 FY2026 financial results, as per Regulation 30 of SEBI (LODR) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Attachments (1)
📄pdf
Download →
4dc25516-8e2e-4c54-b2b8-2ded7dc0388b.pdf
View document text
03rd August 2026
The General Manager, The Manager,
Department of Corporate Services Listing Department
Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited,
Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor,
Dalal Street, Plot No.C/1, 'G' Block,
Mumbai - 400 001. Bandra - Kurla Complex,
Scrip Code - 543308 Mumbai - 400 051.
ISIN: INE967H01025 Symbol - KIMS
ISIN: INE967H01025
Dear Sir,
Sub: Investor Presentation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Investor Presentation on
unaudited (Standalone & Consolidated) financial results of the Company for the 01st quarter ended 30th
June 2026.
The said presentation is being uploaded on the website of the Company i.e.,
https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR)
Regulations, 2015/Analysts Calls schedule, PPT & Transcripts/PPT's.
We request you to take this on record.
Thanking you,
Yours truly,
For Krishna Institute of Medical Sciences Limited
Nagajayanthi J.R
Company Secretary & Compliance Officer
Enclosed: As above
Krishna Institute of Medical Sciences Limited
D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India
Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com
CIN: L55101TG1973PLC040558
Investor Presentation
August 03, 2026
Private & Confidential
Disclaimer
This presentation has been prepared by Krishna Institute of Medical Sciences Limited (the “Company”) solely for informational purposes.
It should not be construed as an offer, solicitation, or recommendation to purchase or subscribe for any securities of the Company or its
affiliates.
The information contained herein has been compiled from sources believed to be reliable; however, the Company makes no representation
or warranty, express or implied, as to the accuracy, completeness, or correctness of such information. Recipients are advised not to
place undue reliance on this presentation and are encouraged to conduct their own independent analysis and consult with professional
advisors before making any investment or business decisions.
This presentation may contain forward-looking statements that involve known and unknown risks, uncertainties, and other factors which
may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied. These
statements reflect the current expectations and beliefs of the Company’s management as of the date hereof and are subject to change
without notice. The Company undertakes no obligation to update or revise any forward-looking statements in light of new information or
future events.
Neither the Company nor any of its directors, officers, employees, affiliates, or advisors accepts any liability whatsoever for any loss, cost,
or damage arising directly or indirectly from the use of this presentation or its contents.
This presentation has not been approved and will not be reviewed or approved by any statutory or regulatory authority in India or by any
stock exchange(s) in India. This material does not purport to be comprehensive or to contain all the information a potential investor may
require. Any investment decision should be based on a thorough review of publicly available information and independent professional
advice suited to the specific circumstances of each investor.
By accessing or attending this presentation, you acknowledge that you understand and agree to the terms of this disclaimer. Any disputes
arising from or relating to this presentation shall be governed by and construed in accordance with the laws of India, and the courts in
Hyderabad, Telangana, India shall have exclusive jurisdiction.
Private & Confidential
Driven by a Vision
Affordable Quality Care
Best-in-Class Facilities
VISION:
S Patient Centric Systems & Processes
To be the most preferred T
healthcare services brand by
providing affordable care and best P
clinical outcomes to patients.
Clinical Outcome Driven Excellence
And to be the best place to work R
O Latest Medical Technology
for doctors and employees.
Strong Academics & Research Oriented
OUR MISSION: Most
Preferred
Provide affordable quality care to
Healthcare
our patients with patient-centric
Enriching Atmosphere
systems and processes.
Provider
EMPLOYEES
Collaborative Culture
Enable clinical outcome-driven
Growth Driven Career Approach
excellence by engaging modern
medical technology. I
Provide a strong impetus for E
doctors to pursue academics and
Transparent Governance
medical research. S
Strong Operational Performance
Consistent Growth
Private & Confidential
Multi Specialty Care
Brain Eyes Bones and Spine Radiology
• Neurology • Ophthalmology • Orthopedics • Imaging
• Neurosurgery • Arthroscopic Surgery • Interventional Radiology
Gastro Intestinal Tract
• Psychiatry • Spine Surgery
• Medical Gastroenterology Lab Services
• Neuro Rehabilitation • Ortho Rehabilitation
• Surgical Gastroenterology • Pathology
Heart • Hepatobiliary Pancreatic Surgery Skin • Microbiology
• Cardiology • Liver Transplant • Dermatology • Biochemistry
• Cardiac Surgery • Bariatric Surgery • Cosmetology • Molecular Biology
• Vascular Surgery • Plastic and Reconstructive Surgery • Clinical Hematology
Genito Urinary Tract
• Heart Transplant
• Nephrology Orthodontics Critical Care Services
• Cardio Rehabilitation
• Urology • Maxillo Facial Surgery • ICU
Lung • Andrology • CTICU
Anaesthesia
• Pulmonology • Renal Transplant • SICU
• OT Anaesthesia
• Interventional Pulmonology • Gynecology • NICU
• Day care Anaesthesia
• Thoracic surgery • Urogynecology • PICU
• Pain Medicine
• Lung Transplant • IVF and ART • Neuro ICU
General Specialities
• Fetal Medicine • ECMO ICU
• Internal Medicine
• Obstetrics • Post Transplant ICU
• General Surgery
• Nose Oncology Hospital Infection Control
• Diabetology & Endocrinology
• Throat • Medical Surgical and Radiation • Clinical Infectious Diseases
Pediatrics
• Head and Neck Surgery • BMT and Hematology
• Pediatrics & Pediatric Sub Specialities
• Neonatology
Private & Confidential
Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS
Chairman & Managing Director
A legend in CT Surgery, Dr. Bhaskara Rao Bollineni {MBBS, MS, DNB (CT Surgery)} is one of the very few
Cardio-Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more
than 25 years.
Well known in the medical fraternity for his passion towards his profession, Dr. Bhaskara Rao Bollineni started
his entrepreneurial journey at “Mahavir Cardio Vascular Centre” in Hyderabad with 50 beds and performed heart
surgeries at an unimaginable low cost of just Rs. 45,000 only. Dr. Bhaskara Rao Bollineni never turned away any
patient from the hospital for want of money.
The brand “Krishna Institute of Medical Sciences”, under Dr. Bhaskara Rao Bollineni aegis began its journey in
2004 with a 300 bed hospital on par with the then established hospitals of Hyderabad in professional excellence,
the state of art technology and infrastructure facilities.
Today KIMS is spread across Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala.
Dr. Bhaskara Rao Bollineni was instrumental in formulating Rajiv Gandhi Aarogyasri scheme, first time launched in
Andhra Pradesh in 2007 for providing health care to the poorest of the poor.
This prestigious scheme has won him accolades from all quarters of the country and the world. He was the chief
architect of Aarogyashri scheme for both creating it and implementing it successfully.
This well formulated scheme has become so popular that the other States in India have emulated it time and again.
Private & Confidential
Dr. Abhinay Bollineni
Executive Director & CEO
Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations
before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as
[Showing first 8,000 characters — download PDF for full document]